Dobutamine potentiates arterial chemoreflex sensitivity in healthy normal humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Velez Roa, Sonia ^a   Kojonazarov, Baktybek ^a   Ciarka, Agnieszka ^c   Godart, Pascal ^a   Naeije, Robert ^a   Somers, Virend K ^b   Van de Borne, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

^b MAYO CLINIC   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Hypoxia

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DOBUTAMINE; PLACEBO;

ADULT; APNEA; ARTICLE; BREATHING; CHEMORECEPTOR REFLEX; CHEMOSENSITIVITY; CLINICAL TRIAL; COLD PRESSOR TEST; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; HEMODYNAMICS; HUMAN; HYPERCAPNIA; HYPOXIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; SYMPATHETIC REFLEX;

EID: 0041857963     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01126.2002     Document Type: Article

References (39)

1. Bainbridge CW and Heistad DD. Effect of haloperidol on ventilatory responses to dopamine in man. J Pharmacol Exp Ther 213: 13-17, 1980.
2. Binet L and Déjours P. Le rôle des chemorécepteurs artériels dans le contrôle de la respiration pulmonaire chez l'homme. Arch Int Pharmacodyn Ther 139: 328-335, 1962.
3. Cohen MI, Gootman PM, and Feldman JL. Inhibition of sympathetic discharge by lung inflation. In: Arterial Baroreceptors and Hypertension, edited by Sleight P. Oxford: Oxford University Press, 1980, p. 161-167.
4. Daly MD, Angell-James JE, and Elsner R. Role of carotid-body chemoreceptors and their reflex interactions in bradycardia and cardiac arrest. Lancet 1: 764-767, 1979.
5. De Burgh Daly M and Scott MJ. An analysis of the primary cardiovascular reflex effects of stimulation of the carotid body chemoreceptors in the dog. Am J Physiol 162: 555-573, 1962.
6. DeKock LL and Dunn AEG. Ultrastructure of carotid body tissue as seen in serial sections. Nature 202: 821, 1964.
7. Delius W, Hagbarth KE, Hongell A, and Wallin BG. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand 84: 65-81, 1972.
8. Delpierre S, Fornaris M, Guillot C, and Grimaud C. Increased ventilatory chemosensitivity induced by domperidone, a dopamine antagonist, in healthy humans. Bull Eur Physiopath Respir 23: 31-35, 1987.
9. Duffin J. Continuing medical education. The chemoreflex control of breathing and its measurement. Can J Anaesth 37: 933-942, 1990.
10. Gonzalez C, Almaraz L, Obeso A, and Rigual R. Oxygen and acid chemoreception in the carotid body chemoreceptors. Trends Neurosci 15: 146-152, 1992.
11. Goodman Gilman A, Rall TW, Nies AS, and Taylor P. Catecholamines and sympathomimetic drugs. In: Goodman and Gilman's the Pharmacological Basis of Therapeutics (8th ed). New York: Pergamon, 1990, p. 202-203.
12. Heistad DD, Abboud FM, Mark AL, and Schmid PG. Interaction of baroreceptor and chemoreceptor reflexes: modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest 53: 1226-1236, 1974.
13. Heistad DD, Wheeler RC, Mark AL, Schmid PG, and Abboud FM. Effects of adrenergic stimulation on ventilation in man. J Clin Invest 51: 1469-1475, 1972.
14. Honig A. Peripheral arterial chemoreceptors and reflex control of sodium and water homeostasis. Am J Physiol Regul Integr Comp Physiol 257: R1282-R1302, 1989.
15. Hornbein TF. The relation between stimulus to chemoreceptors and their response. In: Arterial Chemoreceptors, edited by Torrance RW. Oxford: Blackwell, 1968, p. 65-78.
16. Kressin NA, Nielsen AM, Laravuso R, and Bisgard GE. Domperidone-induced potentiation of ventilatory responses in awake goats. Respir Physiol 65: 169-180, 1986.
17. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, and Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99: 1435-1440, 1999.
18. 2 chemoreception in carotid body. J Appl Physiol 49: 45-51, 1980.
19. Leitch AG, Clancy LJ, Costello JE, and Flenley D. Effects of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia on heart rate and plasma potassium in normal men. Br Med J 1: 365-367, 1976.
20. Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, and Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 81: 141-149, 2001.
21. McDonald DM. Peripheral chemoreceptors. Structure-function relationships of the carotid body. In: Regulation of Breathing, edited by Dekker M. New York: Dekker, 1981, part 1, p. 105-319.
22. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, and Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100: 262-267, 1999.
23. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, and Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97: 943-945, 1998.
24. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, and Somers VK. Selective potentiation of peripheral sensitivity in obstructive sleep apnea. Circulation 99: 1183-1189, 1999.
25. Naughton MT and Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med 19: 99-113, 1998.
26. Nishino T and Lahiri S. Effects of dopamine on chemoreflexes in breathing. J Appl Physiol 50: 892-897, 1981.
27. Olson LG and Saunders NA. Ventilatory stimulation by dopamine-receptor antagonists in the mouse. Br J Pharmacol 85: 133-141, 1985.
28. Olson LG and Saunders NA. Effect of a dopamine antagonist on ventilation during sustained hypoxia in mice. J Appl Physiol 62: 1222-1226, 1987.
29. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A, and Coats AJ. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96: 2586-2594, 1997.
30. Somers VK, Mark AL, and Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 87: 1953-1957, 1991.
31. Teramoto S and Ouchi Y. Clinical significance of arterial blood gas analysis for detection and or treatment of central apnea in patients with heart failure. Circulation 99: 2709-2712, 1999.
32. Van de Borne P, Heron S, Nguyen H, Unger P, Leeman M, Vincent JL, and Degaute JP. Arterial baroreflex control of the sinus node during dobutamine exercice stress testing. Hypertension 33: 987-991, 1999.
33. Van de Borne P, Montano N, Zimmerman B, Pagani M, and Somers VK. Relationship between repeated measures of hemodynamics, muscle sympathetic nerve activity, and their spectral oscillations. Circulation 96: 4326-4332, 1997.
34. Van de Borne P, Oren R, Abouassaly C, Anderson E, and Somers VK. Effect of Cheyne-Stokes respiration on muscle sympathetic activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81: 432-436, 1998.
35. Van de Borne P, Oren R, Anderson EA, Mark AL, and Somers VK. Tonic chemoreflex activation does not contribute to elevated muscle sympathectic nerve activity in heart failure. Circulation 94: 1325-1328, 1996.
36. Van de Borne P, Oren R, Mark AL, and Somers VK. Dopamine depresses minute ventilation in patients with heart failure. Circulation 98: 126-131, 1998.
37. Welsh MJ, Heistad DD, and Abboud FM. Depression of ventilation by dopamine in man: evidence for an effect on the chemoreceptor reflex. J Clin Invest 61: 708-713, 1978.
38. Yamani MH, Haji SA, Starling RC, Kelly L, Albert N, Knack DL, and Young JB. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact. Am Heart J 142: 998-1002, 2001.
39. Yoshiike Y, Susuki S, Watanuki Y, and Okubo T. Effects of fenoterol on ventilatory responses to hypoxia and hypercapnia in normal subjects. Thorax 50: 139-142, 1995.